– Shares of Tesla fell more than 4% after a YouGov survey showed that negative views of the electric vehicle maker have overtaken positive ones just slightly. Tesla's brand has deteriorated after CEO Elon Musk took over Twitter.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stocks making the biggest moves in the premarket: Horizon Therapeutics, Coupa Software, Rivian and moreThe stocks making the biggest moves in premarket trading include Horizon Therapeutics, Coupa Software, Rivian, and more.
Source: CNBC - 🏆 12. / 72 Read more »
Amgen to buy Horizon Therapeutics in $26.4B dealAmgen is spending more than $26 billion to dive deeper into rare disease treatments with the acquisition of drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a treatment for thyroid eye disease that generated more than $1 billion in its first full year on the market. Business Don't talk much to fools
Source: AP - 🏆 728. / 51 Read more »
Amgen Agrees to Deal to Buy Horizon TherapeuticsThe U.S. biotech company agreed to buy drugmaker Horizon Therapeutics in a deal valued at $27.8 billion, marking the largest healthcare merger of the year. Antitrust laws are a joke. Thanks. I’m personally not inexperienced in Pharma & struggling with the size of this deal, overall & on this focus area, which to me can resemble made up diseases for molecule gallery pageants & like negative placebo via DTC ad spam allowed in some markets, most overt missed.
Source: WSJ - 🏆 98. / 63 Read more »
WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon TherapeuticsAmgen is in advanced talks to buy drugmaker Horizon Therapeutics, people familiar with the matter say, in a deal likely to be valued at well over $20 billion Stock Options The people of the world hear our voice👊🏻 Iranian people are fighting against the dictator Support the people of Iran💚🤍❤️ IranRevolution Iran OJO: Amgen dispuesta a comprar Horizon por 20B. Es una adquisición de peso (una de las mayores de los últimos años).La adquisición le daría a Amgen acceso al pipeline de Horizon para enfermedades raras autoinmunes e inflamatorias, incluido su exitoso tratamiento Tepezza.
Source: WSJ - 🏆 98. / 63 Read more »
Amgen reportedly in talks to buy Horizon TherapeuticsThe U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon, according to sources cited by The Wall Street Journal.
Source: MarketWatch - 🏆 3. / 97 Read more »